| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 673.2K | $1.19M | - | |
| Dir | 112.0K | $198.8K | - | |
| Dir | 112.0K | $198.8K | - | |
| Dir | 112.0K | $198.8K | - | |
| Dir | 112.0K | $198.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Wahlstrom Mats66 | Director | Sell | 99,988 | $0.74 | $73,881.13 | -100% | +49.5% | - | |
| Nov 22, 2023 | Lanfear Dennis M | President &CEO | Sale+OE | 223,100 | $2.02 | $449,769.60 | -23.4% | +28.2% | -45.5% | |
| Oct 15, 2021 | Stilwell McDavid | Chief Financial Officer | Sell | 3,507 | $16.80 | $58,918.65 | -10.0% | -18.5% | -51.3% | |
| Sep 29, 2021 | Healy James | Director | Sell | 434,555 | $16.68 | $7,250,063.05 | -41.2% | +5.2% | -43.2% | |
| Jun 9, 2021 | Stilwell McDavid | Chief Financial Officer | Buy | 3,700 | $13.42 | $49,667.69 | +11.8% | +11.7% | -45.9% | |
| Jun 8, 2021 | Lanfear Dennis M | President &CEO | Sale+OE | 31,054 | $13.56 | $421,228.88 | -5.9% | +11.3% | -43.0% | |
| Mar 9, 2021 | Vexler Vladimir | Chief Scientific Officer | Sale+OE | 114,240 | $16.25 | $1,856,262.91 | -68.2% | - | - | |
| Mar 5, 2021 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 26,649 | $15.46 | $412,064.63 | -19.1% | - | - | |
| Feb 17, 2021 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,488 | $17.45 | $43,418.34 | -4.0% | - | - | |
| Feb 1, 2021 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 7,402 | $21.55 | $159,513.10 | -10.8% | - | - |